23andMe Files for Bankruptcy, Notifies Customers of Potential Claims

Genetic testing company 23andMe, once a major player in the industry with a valuation in the billions, has filed for Chapter 11 bankruptcy. The company, along with 11 of its subsidiaries, including Lemonaid Health and LPRXOne, made the decision to seek bankruptcy protection. As part of the restructuring process, 23andMe is now notifying millions of current and former customers that they may be eligible to file claims. Customers have until July 14 to submit their claims. This news has left many customers concerned about the future of their genetic data and the services they have come to rely on. 23andMe has assured customers that their data will be protected and that they are working to ensure a smooth transition during this challenging time. The company’s bankruptcy filing marks a significant turn of events for a company that was once seen as a pioneer in the field of genetic testing. It remains to be seen what the future holds for 23andMe and its customers in the wake of this announcement.